Amplified, lost, and fused genes in 11q23-25 amplicon in acute myeloid leukemia, an array-CGH study

Genes Chromosomes and Cancer

Volumn 45, Issue 3, 2006, Pages 257-264

  Tyybäkinoja, Anne ^a   Saarinen Pihkala, Ulla ^b   Elonen, Erkki ^c   Knuutila, Sakari ^a,d  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

MIXED LINEAGE LEUKEMIA PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AMPLICON; ARTICLE; CASE REPORT; CHROMOSOME 11Q; CHROMOSOME BREAKAGE; COMPARATIVE GENOMIC HYBRIDIZATION; FLII GENE; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE; GENE AMPLIFICATION; GENE FUSION; GENE LOSS; GENE OVEREXPRESSION; HUMAN; KARYOTYPE; MALE; NFRKB GENE; ONCOGENE; PRIORITY JOURNAL; SNX19 GENE;

ACUTE DISEASE; ADOLESCENT; ADULT; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 11; DNA-BINDING PROTEINS; GENE AMPLIFICATION; GENE DELETION; HUMANS; LEUKEMIA, MYELOID; MALE; MYELOID-LYMPHOID LEUKEMIA PROTEIN; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENES; PROTO-ONCOGENE PROTEIN C-FLI-1;

EID: 32544455980     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.20288     Document Type: Article

References (36)

1. Alitalo K, Saksela K, Winqvist R, Alitalo R, Keski-Oja J, Laiho M, Ilvonen M, Knuutila S, de la Chapelle A. 1985. Acute myelogenous leukaemia with c-myc amplification and double minute chromosomes. Lancet 2:1035-1039.
2. Allen RJ, Smith SD, Moldwin RL, Lu MM, Giordano L, Vignon C, Suto Y, Harden A, Tomek R, Veldman T, Ried T, Larson RA, Le Beau MM, Rowley JD, Zeleznik-Le N. 1998. Establishment and characterization of a megakaryoblast cell line with amplification of MLL. Leukemia 12:1119-1127.
3. Andersen MK, Christiansen DH, Kirchhoff M, Pedersen-Bjergaard J. 2001. Duplication or amplification of chromosome band 11q23, including the unrearranged MLL gene, is a recurrent abnormality in therapy-related MDS and AML, and is closely related to mutation of the TP53 gene and to previous therapy with alkylating agents. Genes Chromosomes Cancer 31:33-41.
4. Ariyama Y, Fukuda Y, Okuno Y, Seto M, Date K, Abe T, Nakamura Y, Inazawa J. 1998. Amplification on double-minute chromosomes and partial-tandem duplication of the MLL gene in leukemic cells of a patient with acute myelogenous leukemia. Genes Chromosomes Cancer 23:267-272.
5. Atiye J, Wolf M, Kaur S, Monni O, Böhling T, Kivioja A, Tas É, Serra M, Tarkkanen M, Knuutila S. 2005. Gene amplifications in osteosarcoma-CGH microarray analysis. Genes Chromosomes Cancer 42:158-163.
6. Avet-Loiseau H, Godon C, Li JY, Daviet A, Mellerin MP, Talmant P, Harousseau JL, Bataille R. 1999. Amplification of the 11q23 region in acute myeloid leukemia. Genes Chromosomes Cancer 26:166-170.
7. Coquelle A, Pipiras E, Toledo F, Buttin G, Debatisse M. 1997. Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons. Cell 89:215-225.
8. Crossen PE, Morrison MJ, Rodley P, Cochrane J, Morris CM. 1999. Identification of amplified genes in a patient with acute myeloid leukemia and double minute chromosomes. Cancer Genet Cytogenet 113:126-133.
9. Delattre O, Zucman J, Plougastel B, Desmaze C, Melot T, Peter M, Kovar H, Joubert I, de Jong P, Rouleau G, Aurias A, Thomas G. 1992. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 359:162-165.
10. Erkeland SJ, Valkhof M, Heijmans-Antonissen C, van Hoven-Beijen A, Delwel R, Hermans MH, Touw IP. 2004. Large-scale identification of disease genes involved in acute myeloid leukemia1 J Virol 78:1971-1980.
11. Jacques C, Baris O, Prunier-Mirebeau D, Savagner F, Rodien P, Rohmer V, Franc B, Guyetant S, Malthiery Y, Reynier P. 2005. Two-step differential expression analysis reveals a new set of genes involved in thyroid oncocytic tumors. J Clin Endocrinol Metab 90:2314-2320.
12. Jones C, Penny L, Mattina T, Yu S, Baker E, Voullaire L, Langdon WY, Sutherland GR, Richards RI, Tunnacliffe A. 1995. Association of a chromosome deletion syndrome with a fragile site within the proto-oncogene CBL2. Nature 376:145-149.
13. Jones FS, Kioussi C, Copertino DW, Kallunki P, Holst BD, Edelman GM 1997. Barx2, a new homeobox gene of the Bar class, is expressed in neural and craniofacial structures during development. Proc Natl Acad Sci USA 94:2632-2637.
14. Kakazu N, Taniwaki M, Horiike S, Nishida K, Tatekawa T, Nagai M, Takahashi T, Akaogi T, Inazawa J, Ohki M, Abe T. 1999. Combined spectral karyotyping and DAPI banding analysis of chromosome abnormalities in myelodysplastic syndrome. Genes Chromosomes Cancer 26:336-345.
15. Kourlas PJ, Strout MP, Becknell B, Veronese ML, Croce CM, Theil KS, Krahe R, Ruutu T, Knuutila S, Bloomfield CD, Caligiuri MA. 2000. Identification of a gene at 11q23 encoding a guanine nucleotide exchange factor: evidence for its fusion with MLL in acute myeloid leukemia. Proc Natl Acad Sci USA 97:2145-2150.
16. Lengauer C, Kinzler KW, Vogelstein B. 1998. Genetic instabilities in human cancers. Nature 396:643-649.
17. May WA, Gishizky ML, Lessnick SL, Lunsford LB, Lewis BC, Delattre O, Zucman J, Thomas G, Denny CT. 1993. Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation. Proc Natl Acad Sci USA 90:5752-5756.
18. Michaux L, Wlodarska I, Stul M, Dierlamm J, Mugneret F, Herens C, Beverloo B, Verhest A, Verellen-Dumoulin C, Verhoef G, Selleslag D, Madoe V, Lecomte M, Deprijck B, Ferrant A, Delannoy A, Marichal S, Duhem C, Dicato M, Hagemeijer A. 2000. MLL amplification in myeloid leukemias: a study of 14 cases with multiple copies of 11q23. Genes Chromosomes Cancer 29:40-47.
19. Nacheva E, Kearney L, Bower M, Chaplin T, Douek E, Das S, Young BD. 1993. In situ hybridisation analysis of a homogeneously staining region at 11q23-24 in an acute myeloid leukaemia (M5) using yeast artificial chromosomes. Genes Chromosomes Cancer 7:123-127.
20. Park JP, Ladd SL, Ely P, Weiner NJ, Wojiski SA, Hawk AB, Noll WW, Mohandas TK. 2000. Amplification of the MLL region in acute myeloid leukemia. Cancer Genet Cytogenet 121:198-205.
21. Popescu NC. 2003. Genetic alterations in cancer as a result of breakage at fragile sites. Cancer Lett 192:1-17.
22. Poppe B, Vandesompele J, Schoch C, Lindvall C, Mrozek K, Bloomfield CD, Beverloo HB, Michaux L, Dastugue N, Herens C, Yigit N, De Paepe A, Hagemeijer A, Speleman F. 2004. Expression analyses identify MLL as a prominent target of 11q23 amplification and support an etiologic role for MLL gain of function in myeloid malignancies. Blood 103:229-235.
23. Reuther GW, Lambert QT, Booden MA, Wennerberg K, Becknell B, Marcucci G, Sondek J, Caligiuri MA, Der CJ. 2001. Leukemia-associated Rho guanine nucleotide exchange factor, a Dbl family protein found mutated in leukemia, causes transformation by activation of RhoA. J Biol Chem 276:27145-27151.
24. Rossbach HC, Sutcliffe MJ, Chamizo W, Haag MM, Grana NH, Washington KR, Barbosa JL. 1998. Pre-B acute lymphoblastic leukemia in a 3-year-old boy with pre-acute myelogenous leukemia myelodysplastic syndrome: cytogenetic evidence of common early progenitor cell ontogeny. J Pediatr Hematol Oncol 20:347-352.
25. Rovigatti U, Watson DK, Yunis JJ. 1986. Amplification and rearrangement of Hu-ets-1 in leukemia and lymphoma with involvement of 11q23. Science 232:398-400.
26. Sait SN, Qadir MU, Conroy JM, Matsui S, Nowak NJ, Baer MR. 2002. Double minute chromosomes in acute myeloid leukemia and myelodysplastic syndrome: identification of new amplification regions by fluorescence in situ hybridization and spectral karyotyping. Genes Chromosomes Cancer 34:42-47.
27. Schwab M. 1999. Oncogene amplification in solid tumors. Semin Cancer Biol 9:319-325.
28. Sellar GC, Li L, Watt KP, Nelkin BD, Rabiasz GJ, Stronach EA, Miller EP, Porteous DJ, Smyth JF, Gabra H. 2001. BARX2 induces cadherin 6 expression and is a functional suppressor of ovarian cancer progression. Cancer Res 61:6977-6981.
29. Skacel M, Pettay JD, Tsiftsakis EK, Procop GW, Biscotti CV, Tubbs RR. 2001. Validation of a multicolor interphase fluorescence in situ hybridization assay for detection of transitional cell carcinoma on fresh and archival thin-layer, liquid-based cytology slides. Anal Quant Cytol Histol 23:381-387.
30. Stevens TA, Iacovoni JS, Edelman DB, Meech R. 2004. Identification of novel binding elements and gene targets for the homeodomain protein BARX2. J Biol Chem 279:14520-14530.
31. Streubel B, Valent P, Jäger U, Edelhäuser M, Wandt H, Wagner T, Buchner T, Lechner K, Fonatsch C. 2000. Amplification of the MLL gene on double minutes, a homogeneously staining region, and ring chromosomes in five patients with acute myeloid leukemia or myelodysplastic syndrome. Genes Chromosomes Cancer 27:380-386.
32. Tanaka K, Eguchi M, Eguchi-Ishimae M, Hasegawa A, Ohgami A, Kikuchi M, Kyo T, Asaoku H, Dohy H, Kamada N. 2001. Restricted chromosome breakpoint sites on 11q22-q23.1 and 11q25 in various hematological malignancies without MLL/ALL-1 gene rearrangement. Cancer Genet Cytogenet 124:27-35.
33. Thomas L, Stamberg J, Gojo I, Ning Y, Rapoport AP. 2004. Double minute chromosomes in monoblastic (M5) and myeloblastic (M2) acute myeloid leukemia: two case reports and a review of literature. Am J Hematol 77:55-61.
34. Truong AH, Ben-David Y. 2000. The role of Fli-1 in normal cell function and malignant transformation. Oncogene 19:6482-6489.
35. Yoshida T, Kimura N, Akiyoshi T, Ohshima K, Nagano M, Morioka E, Hisano S, Ohyashiki K, Kamada N, Tamura K. 1999. Jumping translocation of homogeneously staining region and tetraploidy with double minutes in acute myelomonocytic leukemia. Cancer Genet Cytogenetics 109:40-44.
36. Zatkova A, Ullmann R, Rouillard JM, Lamb BJ, Kuick R, Hanash SM, Schnittger S, Schoch C, Fonatsch C, Wimmer K. 2004. Distinct sequences on 11q13.5 and 11q23-24 are frequently coamplified with MLL in complexly organized 11q amplicons in AML/MDS patients. Genes Chromosomes Cancer 39:263-276.